Hunan Jingfeng Pharmaceutical Co.,Ltd.

SZSE:000908 Stock Report

Market Cap: CN¥4.2b

Hunan Jingfeng PharmaceuticalLtd Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 000908?
Owner TypeNumber of SharesOwnership Percentage
State or Government11,083,3691.26%
Individual Insiders130,029,90314.8%
Private Companies130,106,76514.8%
Institutions148,535,21116.9%
General Public460,019,10352.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 17 shareholders own 47.71% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.9%
Xiang Wu Ye
121,902,286CN¥585.1m0.86%no data
12.9%
China Great Wall Asset Management Co., Ltd.
113,680,665CN¥545.7m0%no data
12.9%
China Great Wall Asset Management Corporation, Asset Management Arm
113,680,665CN¥545.7m0%7.67%
1.26%
Pingjiang State-owned Assets Administration Bureau
11,083,369CN¥53.2m0%no data
0.93%
Goldman Sachs Group, Investment Banking and Securities Investments
8,180,548CN¥39.3m0%no data
0.89%
Wei Guang Jian
7,823,117CN¥37.6m0%no data
0.83%
Huayou Health Investment Co., Ltd.
7,322,500CN¥35.1m0%no data
0.78%
CITIC Securities Company Limited, Asset Management Arm
6,862,423CN¥32.9m0%0.03%
0.67%
Everbright Asset Management Co., Ltd.
5,881,987CN¥28.2m0%0.3%
0.66%
Jiangsu Daju Health Industry Investment Co., Ltd.
5,848,000CN¥28.1m0%no data
0.63%
China International Capital Corporation Hong Kong Asset Management Limited
5,583,468CN¥26.8m0%0.13%
0.5%
Shenyin Wanguo Asset Management (Asia) Limited
4,366,931CN¥21.0m0%0.14%
0.44%
Morgan Stanley, Investment Banking and Brokerage Investments
3,912,789CN¥18.8m0%no data
0.37%
Hainan Yada Technology Co., Ltd.
3,255,600CN¥15.6m0%no data
0.035%
Yuan Bi
304,300CN¥1.5m0%no data
0.0076%
Bohai Huijin Securities Asset Management Co., Ltd.
66,400CN¥318.8k0%0.1%
0.00002%
Shendong Zhou
200CN¥844.60%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 02:50
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hunan Jingfeng Pharmaceutical Co.,Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Guohe FanPhillip Securities (HK)
Yin YePing An Securities Co. Ltd.